Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma

• Autor(a) principal: Pereira,Camila Santos
• Data de Publicação: 2013
• Outros Autores: Oliveira,Marcos Vinicius Macedo de, Barros,Lucas Oliveira, Bandeira,Gabriela Alencar, Santos,Sergio Henrique Sousa, Basile,John R., Guimaraes,Andre Luiz Sena, De Paula,Alfredo Mauricio Batista
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Journal of applied oral science (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-77572013000500416
• topic: Squamous cell carcinoma; DNA repair; MutS homolog 2 protein; Immunohistochemistry; Prognosis

OBJECTIVE: This study aimed to investigate the expression of the MSH2 DNA repair protein in head and neck squamous cell carcinoma (HNSCC) in order to analyze its association with clinicopathologic factors and overall survival of patients. MATERIAL AND METHODS: Clinical data and primary lesions of HNSSC were collected from 55 patients who underwent surgical resection with postoperative radiotherapy in Montes Claros, state of Minas Gerais, Brazil, between 2000 and 2008. Immunohistochemical reactions were performed to analyze MSH2 protein expression. RESULTS: Bivariate analysis showed no significant correlation or association between MSH2 expression and clinicopathologic parameters by Mann-Whitney and Kruskal-Wallis tests. Patients with locoregional metastatic disease (OR=4.949, p<0.001) and lower MSH2 immunohistochemical expressions (OR=2.943, p=0.032) presented poorer survival for HNSCC by Cox regression models. CONCLUSIONS: Our data demonstrated that lower MSH2 expression might contribute to a higher clinic aggressiveness of HNSCC by promoting an unfavorable outcome.